Subject matters | Details | Categories |
---|---|---|
Government Procurement, Health, Science and Technology
|
Incyte would be trying to interface with Health Canada (HC) and discuss: Drug Approval and the processes surrounding it, The Patented Medicine Prices Review Board reform, and The Canadian Agency for Drugs and Technologies in Health.
|
Regulation, Legislative Proposal, Bill or Resolution
|
Government Procurement, Science and Technology
|
Incyte would be trying to interface with Innovation, Science and Economic Development Canada (ISED) executives and or associated Federal Departments to discuss: Investing in Canada, Manufacturing in Canada, and Job creation.
|
Policies or Program, Regulation
|
Address:
6500 Transcanada Hwy, Suite 400,
Pointe-Claire, QC H9R 0A5
Canada
Telephone number:
514-862-1662
Web address:
incyte.com
Christine Lennon, Vice President & General Manager
Incyte Biosciences Canada Corporation is not a coalition.
The activities of Incyte Biosciences Canada Corporation are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Incyte Biosciences Canada Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
DAVID ANGUS | Public offices held
Firm: The Capital Hill Group Inc.